• News

UPMC, General Catalyst, Northwell: 16 digital health investments in January

  • Becker’s Hospital Review
  • New York, NY
  • (February 01, 2023)

The Institute for Exposomic Research, Mount Sinai’s precision exposome medicine company, launches LinusBio. LinusBio uses patient blood samples to discover novel biomarkers for diseases and disorders such as autism spectrum disorder, amyotrophic lateral sclerosis (Lou Gehrig's disease), and some cancers.

Learn more